Biomarin Pharmaceutical (BMRN) Inventory (2009 - 2026)
Biomarin Pharmaceutical (BMRN) reported Inventory of $1.78 billion for Q2 2026, up 33.0% from $1.34 billion a year earlier and up 40.0% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Inventory (2009 - 2026) Analysis & Trends
At the end of FY2025, Biomarin Pharmaceutical posted Inventory of $1.3 billion, up 5.4% from FY2024.
- Inventory has increased for 13 consecutive years, with a five-year compound annual growth rate of 13.2% (FY2020 to FY2025).
- By year, Inventory came in at $1.23 billion in FY2024 (+11.3%), $1.11 billion in FY2023 (+23.8%), $894.08 million in FY2022 (+15.1%) and $776.67 million in FY2021 (+11.2%).
- The Q2 2026 figure ranks as the highest quarterly Inventory in data going back to Q4 2009.
- Year over year, Inventory gained in seven of the last eight quarters, with growth averaging 13.3%.
- The high point for year-over-year Inventory in five years was Q2 2026 (growth of 33.0%); the low point was Q1 2026 (a decline of 0.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.27 billion (Q1 2026), $1.3 billion (Q4 2025) and $1.38 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 15.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 5.13 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 6.22 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 6.93 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 6.22 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 9.95 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.77 Bn |
| 10 | Biomarin Pharmaceutical | 11.51 Bn | 5.37 Bn | 786.91 Mn | 1.78 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.78 Bn |
| Mar 31, 2026 | 1.27 Bn |
| Dec 31, 2025 | 1.30 Bn |
| Sep 30, 2025 | 1.38 Bn |
| Jun 30, 2025 | 1.34 Bn |
| Mar 31, 2025 | 1.27 Bn |
| Dec 31, 2024 | 1.23 Bn |
| Sep 30, 2024 | 1.18 Bn |
| Jun 30, 2024 | 1.18 Bn |
| Mar 31, 2024 | 1.14 Bn |
| Dec 31, 2023 | 1.11 Bn |
| Sep 30, 2023 | 1.03 Bn |
| Jun 30, 2023 | 975.55 Mn |
| Mar 31, 2023 | 918.92 Mn |
| Dec 31, 2022 | 894.08 Mn |
| Sep 30, 2022 | 839.46 Mn |
| Jun 30, 2022 | 802.32 Mn |
| Mar 31, 2022 | 786.36 Mn |
| Dec 31, 2021 | 776.67 Mn |
| Sep 30, 2021 | 749.41 Mn |
API Access
Biomarin Pharmaceutical Inventory API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=inventory&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "inventory", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=inventory&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();